In Extensive Clinical Tests, Olumiant Continues to Show Efficacy in Atopic Dermatitis - BioSpace

In Extensive Clinical Tests, Olumiant Continues to Show Efficacy in Atopic Dermatitis  BioSpace

The investigational JAK inhibitor has hit the mark in three late-stage studies, with readouts from two more late-stage trials expected later this year.